Significance of immunohistochemistry biomarkers in prediction of malignant transformation of oral lichen planus: A systematic review
- PMID: 35975803
- PMCID: PMC9445608
- DOI: 10.4317/medoral.25491
Significance of immunohistochemistry biomarkers in prediction of malignant transformation of oral lichen planus: A systematic review
Abstract
Background: Oral lichen planus (OLP) is a chronic inflammatory disorder with increased risk for malignant transformation. Biomarker validation is a pivotal step in moving newly discovered biomarkers towards clinical implementation. We performed a systematic review of studies on biomarkers related to OLP, wherein biomarkers have been described in at least two independent studies. Our aim was to determine whether any of these biomarkers might be promising in predicting the increased risk of malignant transformation of OLP.
Material and methods: We searched the following databases until August 2021: PUBMED, EMBASE, and Web of Science. Due to high heterogeneity, a qualitative rather than quantitative assessment was conducted. Only proteins that consistently showed a significantly high level of expression in neoplastic tissues versus OLP in two or more publications were considered as promising markers.
Results: Initial database researches identified 1671, of which 24 articles were included in the final analysis. The most frequently reported proteins were p53, Bcl-2 and Ki-67, though there were controversies. PCNA and P21 were the only proteins that showed consistent evidence of clinical usefulness as cancer predictors to be considered as promising markers. Extensive methodological variations in the evaluation of expressions and statistical analyses of the included markers were observed, which hampered comparisons of the results.
Conclusions: Multiple levels of heterogeneity with a scarcity of high-quality studies were identified. PCNA and P21 were identified as promising predictive markers for evaluating the risk of malignant transformation of OLP, but they require further validation. The focus of future research on validation of predictive biomarkers of OLP should be considered as a high priority because it will accelerate the introduction of newly discovered markers into the clinical setting.
Conflict of interest statement
Conflicts of interest Authors have no potential conflicts of interest to declare.
Figures
Similar articles
-
Evaluation of Potential Risk Factors that contribute to Malignant Transformation of Oral Lichen Planus: A Literature Review.J Contemp Dent Pract. 2016 Aug 1;17(8):692-701. doi: 10.5005/jp-journals-10024-1914. J Contemp Dent Pract. 2016. PMID: 27659090 Review.
-
Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus.Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):844-9. doi: 10.1158/1055-9965.EPI-09-0699. Epub 2010 Mar 3. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20200437
-
Malignant transformation risk of oral lichen planus: A systematic review and comprehensive meta-analysis.Oral Oncol. 2019 Sep;96:121-130. doi: 10.1016/j.oraloncology.2019.07.012. Epub 2019 Jul 22. Oral Oncol. 2019. PMID: 31422203
-
Rate of malignant transformation of oral lichen planus: A systematic review.Oral Dis. 2019 Apr;25(3):693-709. doi: 10.1111/odi.12885. Epub 2018 Jun 25. Oral Dis. 2019. PMID: 29738106
-
Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression.J Cell Mol Med. 2020 Jan;24(2):1179-1188. doi: 10.1111/jcmm.14376. Epub 2019 Dec 2. J Cell Mol Med. 2020. PMID: 31793175 Free PMC article.
Cited by
-
Comparative Analysis of Different Staining Techniques for Diagnosing Oral Cancer in Tissue Sections.J Pharm Bioallied Sci. 2025 Jun;17(Suppl 2):S1310-S1312. doi: 10.4103/jpbs.jpbs_1951_24. Epub 2025 Jun 18. J Pharm Bioallied Sci. 2025. PMID: 40655650 Free PMC article.
-
Oral Lichen Planus and Oral Squamous Cell Carcinoma share key oncogenic signatures.Sci Rep. 2022 Nov 30;12(1):20645. doi: 10.1038/s41598-022-24801-6. Sci Rep. 2022. PMID: 36450755 Free PMC article.
References
-
- Gonzalez-Moles MA, Warnakulasuriya S, Gonzalez-Ruiz I, Gonzalez-Ruiz L, Ayen A, Lenouvel D. Worldwide prevalence of oral lichen planus: A systematic review and meta-analysis. Oral Dis. 2021;27:813–28. - PubMed
-
- Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol. 2002;46:207–14. - PubMed
-
- Idrees M, Kujan O, Shearston K, Farah CS. Oral lichen planus has a very low malignant transformation rate: A systematic review and meta-analysis using strict diagnostic and inclusion criteria. J Oral Pathol Med. 2021;50:287–98. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous